Back Home Search

HR+/HER2 neg

    • Protocols

    • UW22048

      OPEN TO ACCRUAL

      Ph1 Study of RLY-2608 in PI3KA Solid Tumors & in Combination with Fulvestrant in PI3KA Breast Cancer